No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: FOLFOX in combination with nivolumab and trastuzumab improves survival in metastatic ERBB2⁺ esophagogastric adenocarcinoma

byTeddy Guo

July 20, 2022

in StudyGraphics

Reading Time: 1 min read

Case management program for patient social needs reduces future healthcare use

RelatedReports

Increased risk of subsequent melanoma after first melanoma diagnosis

Dermatology

Neoadjuvant ipilimumab plus nivolumab improves event-free survival in stage III melanoma

December 12, 2024

Cervical cancer screening practices less cost-effective than suggested guidelines

Chronic Disease

Cadonilimab plus chemotherapy improves survival in recurrent or metastatic cervical cancer

December 5, 2024

Chronic Disease

Early Ramucirumab/Paclitaxel vs Continuation of First-line Chemotherapy in Advanced HER2-negative Gastric/Gastroesophageal Cancer

November 25, 2024

Medical vaccine exemptions increase after elimination of nonmedical exemptions

Weekly Rewinds

2 Minute Medicine Rewind November 25, 2024

November 25, 2024

Few older adolescents meet recommended levels of physical activity

Exercise therapy combined with corticosteroid injections associated with clinical improvement of Achilles tendinopathy

Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults

Bridging therapy is superior to direct thrombectomy within 4.5 hours of acute ischemic stroke

Wellness Check: Spirituality

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports